Exercise training-induced modification in autonomic nervous system: An update for cardiac patients

Annals of Physical and Rehabilitation Medicine

Volumn 60, Issue 1, 2017, Pages 27-35

  Besnier, Florent ^a,b   Labrunée, Marc ^a,c   Pathak, Atul ^a,d   Pavy Le Traon, Anne ^a   Galès, Céline ^a   Sénard, Jean Michel ^a   Guiraud, Thibaut ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Clinic of Saint Orens Cardiovascular and Pulmonary Rehabilitation Center   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d CLINIQUE PASTEUR   (France)

Author keywords

Autonomic nervous system; Cardiac rehabilitation; Cardiovascular disease; Chronic heart failure; Exercise training

Indexed keywords

AEROBIC EXERCISE; AUTONOMIC NERVOUS SYSTEM; BREATHING EXERCISE; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; HEART RATE VARIABILITY; HEART REHABILITATION; HIGH INTENSITY INTERVAL TRAINING; HUMAN; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRESSORECEPTOR REFLEX; REVIEW; SYMPATHETIC FUNCTION; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; VAGUS TONE; EXERCISE; HEART RATE; KINESIOTHERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

AUTONOMIC NERVOUS SYSTEM; CARDIAC REHABILITATION; CARDIOVASCULAR DISEASES; EXERCISE; EXERCISE THERAPY; HEART RATE; HUMANS; TREATMENT OUTCOME;

EID: 84994231096     PISSN: 18770657     EISSN: 18770665     Source Type: Journal    
DOI: 10.1016/j.rehab.2016.07.002     Document Type: Review

References (154)

1. [1] Townsend, N., Nichols, M., Scarborough, P., Rayner, M., Cardiovascular disease in Europe – epidemiological update 2015. Eur Heart J 36 (2015), 2696–2705.
2. [2] Nichols, M., Townsend, N., Scarborough, P., Rayner, M., Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35 (2014), 2950–2959.
3. [3] Schlaich, M.P., Lambert, E., Kaye, D.M., et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43 (2004), 169–175.
4. [4] Esler, M., Lambert, E., Schlaich, M., Point: chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 109 (2016), 1996–1998 discussion 2010.
5. [5] Graham, L.N., Smith, P.A., Stoker, J.B., Mackintosh, A.F., Mary, D.A., Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation 106 (2002), 793–797.
6. [6] Hogarth, A.J., Mackintosh, A.F., Mary, D.A., The sympathetic drive after acute myocardial infarction in hypertensive patients. Am J Hypertens 19 (2006), 1070–1076.
7. [7] Floras, J.S., Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 22 (1993), 72A–84A.
8. [8] Schwartz, P.J., De Ferrari, G.M., Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev 16 (2011), 101–107.
9. [9] Kishi, T., Heart failure as an autonomic nervous system dysfunction. J Cardiol 59 (2012), 117–122.
10. [10] Floras, J.S., Ponikowski, P., The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J 36 (2015), 1974–1982.
11. [11] Kaplan, J.R., Pettersson, K., Manuck, S.B., Olsson, G., Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. Circulation 84 (1991), VI23–VI32.
12. [12] Kadoya, M., Koyama, H., Kurajoh, M., et al. Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study. Atherosclerosis 238 (2015), 409–414.
13. [13] Malpas, S.C., Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 90 (2010), 513–557.
14. [14] Floras, J.S., Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54 (2009), 375–385.
15. [15] La Rovere, M.T., Pinna, G.D., Maestri, R., Sleight, P., Clinical value of baroreflex sensitivity. Neth Heart J 21 (2013), 61–63.
16. [16] Coumel, P., The management of clinical arrhythmias. An overview on invasive versus non-invasive electrophysiology. Eur Heart J 8 (1987), 92–99.
17. [17] Vaseghi, M., Shivkumar, K., The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis 50 (2008), 404–419.
18. [18] Wu, L., Jiang, Z., Li, C., Shu, M., Prediction of heart rate variability on cardiac sudden death in heart failure patients: a systematic review. Int J Cardiol 174 (2014), 857–860.
19. [19] Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999), 2001–2007.
20. [20] Kishi, T., Hirooka, Y., Central mechanisms of abnormal sympathoexcitation in chronic heart failure. Cardiol Res Pract, 2012, 2012, 847172.
21. [21] Leenen, F.H., Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 101 (2007), 221–223.
22. [22] Mann, D.L., Bristow, M.R., Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 (2005), 2837–2849.
23. [23] Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., Butler, J., The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54 (2009), 1747–1762.
24. [24] Parati, G., Esler, M., The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 33 (2012), 1058–1066.
25. [25] Goldsmith, S.R., Interactions between the sympathetic nervous system and the RAAS in heart failure. Curr Heart Fail Rep 1 (2004), 45–50.
26. [26] Brack, K.E., Winter, J., Ng, G.A., Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure. Heart Fail Rev 18 (2013), 389–408.
27. [27] Liggett, S.B., Cresci, S., Kelly, R.J., et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med 14 (2008), 510–517.
28. [28] Triposkiadis, F., Parissis, J.T., Starling, R.C., Skoularigis, J., Louridas, G., Current drugs and medical treatment algorithms in the management of acute decompensated heart failure. Expert Opin Invest Drugs 18 (2009), 695–707.
29. [29] He, X., Zhao, M., Bi, X., et al. Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases. Br J Pharmacol, 2014.
30. [30] Singh, J.P., Kandala, J., Camm, A.J., Non-pharmacological modulation of the autonomic tone to treat heart failure. Eur Heart J 35 (2014), 77–85.
31. [31] Hunt, S.A., American College of C and American Heart Association Task Force on Practice G. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005), e1–e82.
32. [32] McMurray, J.J., Adamopoulos, S., Anker, S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
33. [33] Hunt, S.A., Abraham, W.T., Chin, M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (2009), e391–e479.
34. [34] Jessup, M., Abraham, W.T., Casey, D.E., et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (2009), 1977–2016.
35. [35] Perk, J., De Backer, G., Gohlke, H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33 (2012), 1635–1701.
36. [36] Mueller, P.J., Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol 34 (2007), 377–384.
37. [37] Joyner, M.J., Green, D.J., Exercise protects the cardiovascular system: effects beyond traditional risk factors. J Physiol 587 (2009), 5551–5558.
38. [38] Routledge, F.S., Campbell, T.S., McFetridge-Durdle, J.A., Bacon, S.L., Improvements in heart rate variability with exercise therapy. Can J Cardiol 26 (2010), 303–312.
39. [39] Graham, L.N., Smith, P.A., Stoker, J.B., Mackintosh, A.F., Mary, D.A., Sympathetic neural hyperactivity and its normalization following unstable angina and acute myocardial infarction. Clin Sci 106 (2004), 605–611.
40. [40] Hogarth, A.J., Graham, L.N., Mary, D.A., Greenwood, J.P., Gender differences in sympathetic neural activation following uncomplicated acute myocardial infarction. Eur Heart J 30 (2009), 1764–1770.
41. [41] Carthy, E.R., Autonomic dysfunction in essential hypertension: a systematic review. Ann Med Surg 3 (2014), 2–7.
42. [42] Grassi, G., Colombo, M., Seravalle, G., Spaziani, D., Mancia, G., Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31 (1998), 64–67.
43. [43] van de Borne, P., Montano, N., Pagani, M., Oren, R., Somers, V.K., Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95 (1997), 1449–1454.
44. [44] Mimura, J., Yuasa, F., Yuyama, R., et al. The effect of residential exercise training on baroreflex control of heart rate and sympathetic nerve activity in patients with acute myocardial infarction. Chest 127 (2005), 1108–1115.
45. [45] Notarius, C.F., Millar, P.J., Floras, J.S., Muscle sympathetic activity in resting and exercising humans with and without heart failure. Appl Physiol Nutr Metab 40 (2015), 1107–1115.
46. [46] Antunes-Correa, L.M., Melo, R.C., Nobre, T.S., et al. Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure. Eur J Heart Fail 12 (2010), 58–65.
47. [47] Antunes-Correa, L.M., Kanamura, B.Y., Melo, R.C., et al. Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age. Eur J Prev Cardiol 19 (2012), 822–829.
48. [48] Roveda, F., Middlekauff, H.R., Rondon, M.U., et al. The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42 (2003), 854–860.
49. [49] Fraga, R., Franco, F.G., Roveda, F., et al. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail 9 (2007), 630–636.
50. [50] de Mello Franco, F.G., Santos, A.C., Rondon, M.U., et al. Effects of home-based exercise training on neurovascular control in patients with heart failure. Eur J Heart Fail 8 (2006), 851–855.
51. [51] Martinez, D.G., Nicolau, J.C., Lage, R.L., et al. Effects of long-term exercise training on autonomic control in myocardial infarction patients. Hypertension 58 (2011), 1049–1056.
52. [52] Task Force of ESC & NASPE, Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17 (1996), 354–381.
53. [53] Freeman, J.V., Dewey, F.E., Hadley, D.M., Myers, J., Froelicher, V.F., Autonomic nervous system interaction with the cardiovascular system during exercise. Prog Cardiovasc Dis 48 (2006), 342–362.
54. [54] Lahiri, M.K., Kannankeril, P.J., Goldberger, J.J., Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51 (2008), 1725–1733.
55. [55] Nolan, J., Batin, P.D., Andrews, R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 (1998), 1510–1516.
56. [56] Galinier, M., Pathak, A., Fourcade, J., et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 21 (2000), 475–482.
57. [57] McMillan, D.E., Interpreting heart rate variability sleep/wake patterns in cardiac patients. J Cardiovasc Nurs 17 (2002), 69–81.
58. [58] Bilchick, K.C., Fetics, B., Djoukeng, R., et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol 90 (2002), 24–28.
59. [59] La Rovere, M.T., Pinna, G.D., Hohnloser, S.H., et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103 (2001), 2072–2077.
60. [60] Kiilavuori, K., Toivonen, L., Naveri, H., Leinonen, H., Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J 16 (1995), 490–495.
61. [61] Malfatto, G., Branzi, G., Riva, B., Sala, L., Leonetti, G., Facchini, M., Recovery of cardiac autonomic responsiveness with low-intensity physical training in patients with chronic heart failure. Eur J Heart Fail 4 (2002), 159–166.
62. [62] Selig, S.E., Carey, M.F., Menzies, D.G., et al. Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow. J Card Fail 10 (2004), 21–30.
63. [63] Larsen, A.I., Gjesdal, K., Hall, C., Aukrust, P., Aarsland, T., Dickstein, K., Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability. Eur J Cardiovasc Prev Rehabil 11 (2004), 162–167.
64. [64] Murad, K., Brubaker, P.H., Fitzgerald, D.M., et al. Exercise training improves heart rate variability in older patients with heart failure: a randomized, controlled, single-blinded trial. Congest Heart Fail 18 (2012), 192–197.
65. [65] Iellamo, F., Manzi, V., Caminiti, G., et al. Dose–response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure. Int J Cardiol 166 (2013), 334–339.
66. [66] Duru, F., Candinas, R., Dziekan, G., Goebbels, U., Myers, J., Dubach, P., Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction. Am Heart J 140 (2000), 157–161.
67. [67] La Rovere, M.T., Mortara, A., Sandrone, G., Lombardi, F., Autonomic nervous system adaptations to short-term exercise training. Chest 101 (1992), 299S–303S.
68. [68] Santos-Hiss, M.D., Melo, R.C., Neves, V.R., et al. Effects of progressive exercise during phase I cardiac rehabilitation on the heart rate variability of patients with acute myocardial infarction. Disabil Rehabil 33 (2011), 835–842.
69. [69] Holstein, G.R., Martinelli, G.P., Friedrich, V.L., Anatomical observations of the caudal vestibulo-sympathetic pathway. J Vestib Res Equilib Orientat 21 (2011), 49–62.
70. [70] Biaggioni, I., Whetsell, W.O., Jobe, J., Nadeau, J.H., Baroreflex failure in a patient with central nervous system lesions involving the nucleus tractus solitarii. Hypertension 23 (1994), 491–495.
71. [71] Yamazaki, F., Tsutsui, Y., Endo, Y., Sagawa, S., Shiraki, K., Baroreflex control of the heart rate during central hypovolemic stress in young and elderly men. J UOEH 26 (2004), 179–192.
72. [72] Eckberg, D.L., Drabinsky, M., Braunwald, E., Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285 (1971), 877–883.
73. [73] Zucker, I.H., Wang, W., Modulation of baroreflex and baroreceptor function in experimental heart failure. Basic Res Cardiol 86:Suppl 3 (1991), 133–148.
74. [74] La Rovere, M.T., Maestri, R., Robbi, E., et al. Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure. J Hypertens 29 (2011), 1546–1552.
75. [75] Zucker, I.H., Patel, K.P., Schultz, H.D., Neurohumoral stimulation. Heart Fail Clin 8 (2012), 87–99.
76. [76] La Rovere, M.T., Bigger, J.T. Jr., Marcus, F.I., Mortara, A., Schwartz, P.J., Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351 (1998), 478–484.
77. [77] Wang, W., Chen, J.S., Zucker, I.H., Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 81 (1990), 1959–1966.
78. [78] Wang, W., Chen, J.S., Zucker, I.H., Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ Res 68 (1991), 1294–1301.
79. [79] Wang, W., Chen, J.S., Zucker, I.H., Postexcitatory depression of baroreceptors in dogs with experimental heart failure. Am J Physiol 260 (1991), H1160–H1165.
80. [80] Tu, H., Zhang, L., Tran, T.P., Muelleman, R.L., Li, Y.L., Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats. J Neurosci Res 88 (2010), 3337–3349.
81. [81] Wang, W., McClain, J.M., Zucker, I.H., Aldosterone reduces baroreceptor discharge in the dog. Hypertension 19 (1992), 270–277.
82. [82] Zucker, I.H., Liu, J.L., Angiotensin II–nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail Rev 5 (2000), 27–43.
83. [83] Zucker, I.H., Wang, W., Brandle, M., Schultz, H.D., Patel, K.P., Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis 37 (1995), 397–414.
84. [84] Mousa, T.M., Liu, D., Cornish, K.G., Zucker, I.H., Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure. J Appl Physiol 104 (2008), 616–624.
85. [85] Liu, J.L., Kulakofsky, J., Zucker, I.H., Exercise training enhances baroreflex control of heart rate by a vagal mechanism in rabbits with heart failure. J Appl Physiol 92 (2002), 2403–2408.
86. [86] Rondon, E., Brasileiro-Santos, M.S., Moreira, E.D., et al. Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 291 (2006), H2801–H2806.
87. [87] Pietila, M., Malminiemi, K., Vesalainen, R., et al. Exercise training in chronic heart failure: beneficial effects on cardiac (11)C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization. J Nucl Med 43 (2002), 773–779.
88. [88] Groehs, R.V., Toschi-Dias, E., Antunes-Correa, L.M., et al. Exercise training prevents the deterioration in the arterial baroreflex control of sympathetic nerve activity in chronic heart failure. Am J Physiol Heart Circ Physiol, 2015 ajpheart 00723 2014.
89. [89] Groehs, R.V., Toschi-Dias, E., Antunes-Correa, L.M., et al. Exercise training prevents the deterioration in the arterial baroreflex control of sympathetic nerve activity in chronic heart failure patients. Am J Physiol Heart Circ Physiol 308 (2015), H1096–H1102.
90. [90] Lechat, P., Hulot, J.S., Escolano, S., et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103 (2001), 1428–1433.
91. [91] Jouven, X., Empana, J.P., Schwartz, P.J., Desnos, M., Courbon, D., Ducimetiere, P., Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352 (2005), 1951–1958.
92. [92] Cook, S., Togni, M., Schaub, M.C., Wenaweser, P., Hess, O.M., High heart rate: a cardiovascular risk factor?. Eur Heart J 27 (2006), 2387–2393.
93. [93] Fox, K., Borer, J.S., Camm, A.J., et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50 (2007), 823–830.
94. [94] Hjalmarson, A., Significance of reduction in heart rate in cardiovascular disease. Clin Cardiol 21 (1998), II3–II7.
95. [95] Fosbol, E.L., Seibaek, M., Brendorp, B., et al. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study. Int J Cardiol 140 (2010), 279–286.
96. [96] Bohm, M., Reil, J.C., Deedwania, P., Kim, J.B., Borer, J.S., Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med 128 (2015), 219–228.
97. [97] Caetano, J., Delgado Alves, J., Heart rate and cardiovascular protection. Eur J Intern Med, 2015.
98. [98] Khan, H., Kunutsor, S., Kalogeropoulos, A.P., et al. Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis. J Am Heart Assoc, 4, 2015, e001364.
99. [99] Dobre, D., van Veldhuisen, D.J., DeJongste, M.J., et al. Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival. Eur J Heart Fail 9 (2007), 280–286.
100. [100] Cucherat, M., Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J 28 (2007), 3012–3019.
101. [101] Adams, B.J., Carr, J.G., Ozonoff, A., Lauer, M.S., Balady, G.J., Effect of exercise training in supervised cardiac rehabilitation programs on prognostic variables from the exercise tolerance test. Am J Cardiol 101 (2008), 1403–1407.
102. [102] Tabet, J.Y., Meurin, P., Driss, A.B., et al. Benefits of exercise training in chronic heart failure. Arch Cardiovasc Dis 102 (2009), 721–730.
103. [103] Rengo, G., Pagano, G., Parisi, V., et al. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure. Int J Cardiol 171 (2014), 384–389.
104. [104] Myers, J., Hadley, D., Oswald, U., et al. Effects of exercise training on heart rate recovery in patients with chronic heart failure. Am Heart J 153 (2007), 1056–1063.
105. [105] Pierpont, G.L., Stolpman, D.R., Gornick, C.C., Heart rate recovery post-exercise as an index of parasympathetic activity. J Auton Nerv Syst 80 (2000), 169–174.
106. [106] Watanabe, J., Thamilarasan, M., Blackstone, E.H., Thomas, J.D., Lauer, M.S., Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation 104 (2001), 1911–1916.
107. [107] Arena, R., Guazzi, M., Myers, J., Peberdy, M.A., Prognostic value of heart rate recovery in patients with heart failure. Am Heart J, 151, 2006, 851 e7–13.
108. [108] Cole, C.R., Blackstone, E.H., Pashkow, F.J., Snader, C.E., Lauer, M.S., Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341 (1999), 1351–1357.
109. [109] Nishime, E.O., Cole, C.R., Blackstone, E.H., Pashkow, F.J., Lauer, M.S., Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 284 (2000), 1392–1398.
110. [110] Imai, K., Sato, H., Hori, M., et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol 24 (1994), 1529–1535.
111. [111] Racine, N., Blanchet, M., Ducharme, A., et al. Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy. J Card Fail 9 (2003), 296–302.
112. [112] Dimopoulos, S., Anastasiou-Nana, M., Sakellariou, D., et al. Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 13 (2006), 67–73.
113. [113] Kligfield, P., McCormick, A., Chai, A., Jacobson, A., Feuerstadt, P., Hao, S.C., Effect of age and gender on heart rate recovery after submaximal exercise during cardiac rehabilitation in patients with angina pectoris, recent acute myocardial infarction, or coronary bypass surgery. Am J Cardiol 92 (2003), 600–603.
114. [114] Giallauria, F., De Lorenzo, A., Pilerci, F., et al. Long-term effects of cardiac rehabilitation on end-exercise heart rate recovery after myocardial infarction. Eur J Cardiovasc Prev Rehabil 13 (2006), 544–550.
115. [115] Duarte, A., Soares, P.P., Pescatello, L., Farinatti, P., Aerobic training improves vagal reactivation regardless of resting vagal control. Med Sci Sports Exerc, 2014.
116. [116] Kiilavuori, K., Naveri, H., Leinonen, H., Harkonen, M., The effect of physical training on hormonal status and exertional hormonal response in patients with chronic congestive heart failure. Eur Heart J 20 (1999), 456–464.
117. [117] Patel, K.P., Zheng, H., Central neural control of sympathetic nerve activity in heart failure following exercise training. Am J Physiol Heart Circ Physiol 302 (2012), H527–H537.
118. [118] Haack, K.K., Zucker, I.H., Central mechanisms for exercise training-induced reduction in sympatho-excitation in chronic heart failure. Auton Neurosci Basic Clin 188 (2015), 44–50.
119. [119] Zheng, H., Li, Y.F., Cornish, K.G., Zucker, I.H., Patel, K.P., Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure. Am J Physiol Heart Circ Physiol 288 (2005), H2332–H2341.
120. [120] Kar, S., Gao, L., Zucker, I.H., Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J Appl Physiol 108 (2010), 923–932.
121. [121] Felix, J.V., Michelini, L.C., Training-induced pressure fall in spontaneously hypertensive rats is associated with reduced angiotensinogen mRNA expression within the nucleus tractus solitarii. Hypertension 50 (2007), 780–785.
122. [122] Piepoli, M.F., Conraads, V., Corra, U., et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 13 (2011), 347–357.
123. [123] Meyer, P., Gayda, M., Juneau, M., Nigam, A., High-intensity aerobic interval exercise in chronic heart failure. Curr Heart Fail Rep 10 (2013), 130–138.
124. [124] Arena, R., Myers, J., Forman, D.E., Lavie, C.J., Guazzi, M., Should high-intensity-aerobic interval training become the clinical standard in heart failure?. Heart Fail Rev 18 (2013), 95–105.
125. [125] Balady, G.J., Williams, M.A., Ades, P.A., et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 115 (2007), 2675–2682.
126. [126] Wisloff, U., Stoylen, A., Loennechen, J.P., et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115 (2007), 3086–3094.
127. [127] Freyssin, C., Verkindt, C., Prieur, F., Benaich, P., Maunier, S., Blanc, P., Cardiac rehabilitation in chronic heart failure: effect of an 8-week, high-intensity interval training versus continuous training. Arch Phys Med Rehabil 93 (2012), 1359–1364.
128. [128] Haykowsky, M.J., Timmons, M.P., Kruger, C., McNeely, M., Taylor, D.A., Clark, A.M., Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions. Am J Cardiol 111 (2013), 1466–1469.
129. [129] Gayda, M., Ribeiro, P.A., Juneau, M., Nigam, A., Comparison of different forms of exercise training in cardiac patients: where does high-intensity interval training fit?. Can J Cardiol, 2016, 10.1016/jcjca201601017.
130. [130] Guiraud, T., Labrunee, M., Gaucher-Cazalis, K., et al. High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure. Med Sci Sports Exerc 45 (2013), 1861–1867.
131. [131] Guiraud, T., Nigam, A., Gremeaux, V., Meyer, P., Juneau, M., Bosquet, L., High-intensity interval training in cardiac rehabilitation. Sports Med 42 (2012), 587–605.
132. [132] Guiraud, T., Nigam, A., Juneau, M., Meyer, P., Gayda, M., Bosquet, L., Acute responses to high-intensity intermittent exercise in CHD patients. Med Sci Sports Exerc 43 (2011), 211–217.
133. [133] Meyer, P., Normandin, E., Gayda, M., et al. High-intensity interval exercise in chronic heart failure: protocol optimization. J Card Fail 18 (2012), 126–133.
134. [134] Le, V.V., Mitiku, T., Hadley, D., Myers, J., Froelicher, V.F., Rest premature ventricular contractions on routine ECG and prognosis in heart failure patients. Ann Noninvasive Electrocardiol 15 (2010), 56–62.
135. [135] Munk, P.S., Butt, N., Larsen, A.I., High-intensity interval exercise training improves heart rate variability in patients following percutaneous coronary intervention for angina pectoris. Int J Cardiol 145 (2010), 312–314.
136. [136] Parpa, K.M., Michaelides, M.A., Brown, B.S., Effect of high intensity interval training on heart rate variability in individuals with type 2 diabetes. JEPonline 2009 12 (2009), 23–29.
137. [137] Currie, K.D., Rosen, L.M., Millar, P.J., McKelvie, R.S., MacDonald, M.J., Heart rate recovery and heart rate variability are unchanged in patients with coronary artery disease following 12 weeks of high-intensity interval and moderate-intensity endurance exercise training. Appl Physiol Nutr Metab 38 (2013), 644–650.
138. [138] Lehrer, P.M., Vaschillo, E., Vaschillo, B., Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback 25 (2000), 177–191.
139. [139] Lin, G., Xiang, Q., Fu, X., et al. Heart rate variability biofeedback decreases blood pressure in prehypertensive subjects by improving autonomic function and baroreflex. J Altern Complement Med 18 (2012), 143–152.
140. [140] Ray, I.B., Menezes, A.R., Malur, P., Hiltbold, A.E., Reilly, J.P., Lavie, C.J., Meditation and coronary heart disease: a review of the current clinical evidence. Ochsner J 14 (2014), 696–703.
141. [141] Swanson, K.S., Gevirtz, R.N., Brown, M., Spira, J., Guarneri, E., Stoletniy, L., The effect of biofeedback on function in patients with heart failure. Appl Psychophysiol Biofeedback 34 (2009), 71–91.
142. [142] Bernardi, L., Porta, C., Spicuzza, L., et al. Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation 105 (2002), 143–145.
143. [143] Kwekkeboom, K.L., Bratzke, L.C., A systematic review of relaxation, meditation, and guided imagery strategies for symptom management in heart failure. J Cardiovasc Nurs, 2015.
144. [144] Amihai, I., Kozhevnikov, M., The influence of Buddhist meditation traditions on the autonomic system and attention. BioMed Res Int, 2015, 2015, 731579.
145. [145] Curiati, J.A., Bocchi, E., Freire, J.O., et al. Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. J Altern Complement Med 11 (2005), 465–472.
146. [146] Labrunee, M., Despas, F., Marque, P., et al. Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study). PLoS ONE, 8, 2013, e79438.
147. [147] Potts, J.T., Fuchs, I.E., Li, J., Leshnower, B., Mitchell, J.H., Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized cats. J Physiol 514:Pt 3 (1999), 829–841.
148. [148] Buchheit, M., Gindre, C., Cardiac parasympathetic regulation: respective associations with cardiorespiratory fitness and training load. Am J Physiol Heart Circ Physiol 291 (2006), H451–H458.
149. [149] Stanley, J., Peake, J.M., Buchheit, M., Cardiac parasympathetic reactivation following exercise: implications for training prescription. Sports Med 43 (2013), 1259–1277.
150. [150] Kiviniemi, A.M., Hautala, A.J., Kinnunen, H., et al. Daily exercise prescription on the basis of HR variability among men and women. Med Sci Sports Exerc 42 (2010), 1355–1363.
151. [151] Hautala, A.J., Kiviniemi, A.M., Tulppo, M.P., Individual responses to aerobic exercise: the role of the autonomic nervous system. Neurosci Biobehav Rev 33 (2009), 107–115.
152. [152] Compostella, L., Nicola, R., Tiziana, S., Caterina, C., Fabio, B., Autonomic dysfunction predicts poor physical improvement after cardiac rehabilitation in patients with heart failure. Res Cardiovasc Med, 3, 2014, e25237.
153. [153] Kiviniemi, A.M., Hautala, A.J., Kinnunen, H., Tulppo, M.P., Endurance training guided individually by daily heart rate variability measurements. Eur J Appl Physiol 101 (2007), 743–751.
154. [154] Borg, G.A., Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982), 377–381.